2nd Annual  Substance Addiction Research Training Retreat-Live

Actions Panel

2nd Annual Substance Addiction Research Training Retreat-Live

Highlights of Substance Use Research at CDU/UCLA/UC-Irvine/USC/CSUSB with keynote speakers Wilson Compton, M.D. and Adam Leventhal, Ph.D.

By Charles R. Drew University

When and where

Date and time

Friday, June 9 · 8am - 4pm PDT


The California Endowment Center 1000 North Alameda Street Los Angeles, CA 90012

About this event

  • 8 hours
  • Mobile eTicket

Target Audience

Substance use researchers, students, trainees, physicians, pharmacists, social workers, substance abuse counselors

This is the live event. Click here if you want to register for the zoom event

Parking is free and breakfast, lunch and afternoon snack will be served.

This year will include five training and research programs in Southern California: *UCLA T32 Program in the Translational Neuroscience of Drug Abuse *UC Irvine T32 Training Program in Substance Use and Use Disorders *Charles Drew Medical University *Univ. Southern California Institute for Addiction Science *CA State Univ. San Bernardino Smoke and Tobacco Outreach and Prevention Scholar (STOPS) program.

UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

UCLA Integrated Substance Abuse Programs (ISAP) designates this live in-person/live virtual training course for a maximum of number (2.0) AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.

Continuing medical education will be awarded within 6-8 weeks following completion of the training.

Upon completion of this session, participants will be able to:

1. Recall three current topics in neuroscience addiction research.

2. Distinguish two methods used in clinical-translational addiction research.

3. Analyze two findings that support the therapeutic use of microdosing in treating substance use disorders.

4. Recognize three current topics that are research priorities at the National Institute on Drug Abuse.

5. Specify three components of health disparities in equity related to addiction treatment.

Featured Speakers

Wilson M. Compton, M.D., M.P.E., Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health.

Adam Leventhal, Ph.D., Professor:University of Southern California School of Medicine


7:30-8:15 Registration and Breakfast

8:15-8:30 Introduction to Southern California Substance Addiction Research Training Retreat Theodore C. Friedman M.D., Ph.D.

8:30-9:30: Highlights of Basic Neuroscience/ Drug Addiction Research

Juan Carlos Rivera, Ph.D., David Sanchez, Ph.D., Emily Marie Castro, Ph.D., Lindsay Lueptow, Ph.D.

9:30-10:30 Highlights of Clinical/Translational Neuroscience/ Drug Addiction Research

Elisa Pabon, Ph.D., Alexandra Donovan, Ph.D., Alyssa Harlow, Ph.D., Dylan Kirsch, Ph.D.

10:30-11:30: Keynote Speaker: Wilson M. Compton, M.D., M.P.E Drug Addiction Science and the U.S. Overdose Epidemic#

11:30-12:30 Lunch and Networking

12:30-1:30 Keynote Speaker: Adam Leventhal, Ph.D. Addiction Science: More Substance Than You Might Think#

1:35-2:35 Breakout Sessions A

Emerging Pharmaceutical Targets for Substance Use Disorder

Liana Asatryan, Ph.D., Steven Shoptaw Ph.D., Larissa Mooney, M.D.


Medical use of Psychedelics Brad Conner, Ph.D., Harriet De Wit, Ph.D., Conor Murray, Ph.D.

2:40-3:40 Breakout Sessions B

Health Disparities of Substance Use Disorders Shervin Assari,M.D., MPH, Angie Otiniano Verissimo, Ph.D., Andrew Subica, Ph.D.

Or Detrimental and beneficial effects of Cannabis Linda Richter, Ph.D., Daniele Piomelli, Ph.D., Scott Hunter, M.D., Elisa Pabon, Ph.D.

3:40-4:00 Synopsis of Breakout/ Wrap-up/ Evaluation

Wilson M. Compton, M.D., M.P.E., Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health.

Adam Leventhal, Ph.D., Professor: University of Southern California School of Medicine

About the organizer

The Substance Abuse Disorders Research Training (SART) is funded by the National Institute on Drug Abuse (Grant # 1R25DA050723) and is designed to advance substance abuse research skills and to reduce health disparities in substance use disorders and addiction.